What is (RFA) Therapy?
Chronic Heartburn Can Be Serious
Chronic heartburn can be annoying, but more than that, it can also increase your likelihood of developing a more serious disease called Barrett’s esophagus. Barrett’s esophagus is the primary risk factor for esophageal adenocarcinoma (EAC).1-2 That’s why early diagnosis and treatment is so important.
If you or a loved one suffer from chronic heartburn or from gastrointestinal reflux disease (GERD), it’s important to understand that these conditions can progress to something more serious, such as Barrett’s esophagus.
We can help. Please contact us to schedule a consultation.
What is Barrett’s esophagus?
Barrett’s esophagus is a change that occurs within the cellular lining of the esophagus — the swallowing tube that carries foods and liquids from the mouth to the stomach. It is a pre-cancerous condition that is caused by chronic backwash of stomach contents, such as acids and enzymes.1
It’s more common than you may think: About 12 million American adults have Barrett’s esophagus, but only 1.5 million have been diagnosed.3
What are the symptoms of Barrett’s esophagus?
People with Barrett’s esophagus may not have any symptoms, but if you have the following, it may indicate a need for further testing:4
- Chronic heartburn
- Difficulty swallowing
- Chest pain
Who is at risk?
Factors that may put you at risk for Barrett’s esophagus include: obesity, Caucasian ethnicity, family history of Barrett’s esophagus or esophageal cancer, and being male.2 Up to 26.5 percent of people with chronic GERD may develop Barrett’s esophagus in their lifetime.5
It’s important to note that when diagnosis and treatment are delayed, chronic GERD can increase the risk for Barrett’s esophagus.5
How is Barrett’s esophagus diagnosed?
We will want to visualize your esophagus first. We do this using an endoscope, in which a small flexible tube with a light at the end (the endoscope) is passed through the mouth and into the esophagus. This tube has a camera that allows us to look at the lining of the esophagus.
During the endoscopy, if we see any abnormalities, we may take a sample of the tissue to confirm the diagnosis and determine severity.
1. Gilbert EW, Luna RA, Harrison VL, Hunter JG. Barrett’s esophagus: a review of the literature. J Gastrointest Surg. 2011;15:708-18.
2. Spechler SJ, Souza RF. Barrett’s esophagus. NEJM. 2014;371:836-45.
3. Dymedex Market Development Consulting, GERD Sizing and Segmentation for pH Testing, February 13 2015.
4. Shaheen NJ, Richter JE. Barrett’s oesophagus. Lancet. 2009;373(9666):850-61.
5. Dymedex Market Development Consulting, GERD Sizing and Segmentation for pH Testing. February 13, 2015.
Results may vary. Keep in mind that all treatment and outcome results are specific to the individual patient. Please consult your physician for a full list of indications, warnings, precautions, adverse events, clinical results, and other important medical information.
Caution: Federal law restricts this device to sale by or on the order of a licensed healthcare practitioner. Rx only.
Risk Information: The following are transient side effects that may be expected after treatment: chest pain, difficulty swallowing, painful swallowing, throat pain and/or fever. Complications observed at a very low frequency include: mucosal laceration, minor and major acute bleeding, stricture, perforation, cardiac arrhythmia, pleural effusion, aspiration, and infection. Potential complications that have not been observed include: death. Please refer to the product user manual or medtronic.com/gi for detailed information.